Free Annual Reports
Priceline.com and More Big Movers on the Nasdaq on December 10, 2012
This morning has been good for the market. The Nasdaq has moved up 0.6%; the S&P 500 is trading up 0.2%; and the Dow has increased 0.3%. The recent surge in popularity of technological stocks has launched the Nasdaq Composite Index into the spotlight, making it one of the premier indexes in the world.
The biggest movers traded on the NASDAQ so far are:
Broker Summary: E-Trade Financial
After a big jump of 10.9%, Infinity Pharmaceuticals (Nasdaq:INFI) is trading at $24.98 per share. This morning, the company is trading a volume of two million shares.
At $39.93, Deckers (Nasdaq:DECK) has slipped 6.6%. The company's volume for the day so far is 1.6 million shares, in keeping with its current three-month average.
Concur Technologies (Nasdaq:CNQR) has risen 5.7% to hit a current price of $65.37 per share. The company's volume is currently 590,742 shares. This is more trading activity than there was yesterday.
Mellanox (Nasdaq:MLNX) is at $71.54 per share after an increase of 4.6%. So far today, the company's volume is 267,731 shares, 0.2 times the average daily volume.
Pharmacyclics (Nasdaq:PCYC) has risen 4.4% and is currently trading at $58.46 per share. So far today, the company's volume is 513,619 shares.
Slipping 4.1%, Priceline.com (Nasdaq:PCLN) is currently trading at $631.97 per share. So far today, the company's volume is 679,175 shares, 1.1 times its average over the past three months.
After a decline of 3.4%, Expedia (Nasdaq:EXPE) has hit a share price of $57.85. The company is trading at a volume of 1.2 million shares. This is on pace to reach yesterday's trading volume of 2.6 million shares.
The Bottom Line The nature of the market is such that stocks will have good days and bad days. Paying close attention to the previous ratios will help you identify key times to adjust your strategy. Tools like valuation ratios and profit margins, however, are only as useful as the context you put them in; remember to take historical data and competitor performance into account.
The biggest movers traded on the NASDAQ so far are:
| Company | Market Cap | Percentage Change |
| Infinity Pharmaceuticals (Nasdaq:INFI) | $889.3 million | +10.9% |
| Deckers (Nasdaq:DECK) | $1.51 billion | -6.6% |
| Concur Technologies (Nasdaq:CNQR) | $3.4 billion | +5.7% |
| Mellanox (Nasdaq:MLNX) | $2.89 billion | +4.6% |
| Pharmacyclics (Nasdaq:PCYC) | $3.9 billion | +4.4% |
| Priceline.com (Nasdaq:PCLN) | $32.87 billion | -4.1% |
| Expedia (Nasdaq:EXPE) | $8.08 billion | -3.4% |
After a big jump of 10.9%, Infinity Pharmaceuticals (Nasdaq:INFI) is trading at $24.98 per share. This morning, the company is trading a volume of two million shares.
At $39.93, Deckers (Nasdaq:DECK) has slipped 6.6%. The company's volume for the day so far is 1.6 million shares, in keeping with its current three-month average.
Concur Technologies (Nasdaq:CNQR) has risen 5.7% to hit a current price of $65.37 per share. The company's volume is currently 590,742 shares. This is more trading activity than there was yesterday.
Pharmacyclics (Nasdaq:PCYC) has risen 4.4% and is currently trading at $58.46 per share. So far today, the company's volume is 513,619 shares.
Slipping 4.1%, Priceline.com (Nasdaq:PCLN) is currently trading at $631.97 per share. So far today, the company's volume is 679,175 shares, 1.1 times its average over the past three months.
After a decline of 3.4%, Expedia (Nasdaq:EXPE) has hit a share price of $57.85. The company is trading at a volume of 1.2 million shares. This is on pace to reach yesterday's trading volume of 2.6 million shares.
The Bottom Line The nature of the market is such that stocks will have good days and bad days. Paying close attention to the previous ratios will help you identify key times to adjust your strategy. Tools like valuation ratios and profit margins, however, are only as useful as the context you put them in; remember to take historical data and competitor performance into account.
by
Investopedia Staff
Investopedia.com believes that individuals can excel at managing their financial affairs. As such, we strive to provide free educational content and tools to empower individual investors, including thousands of original and objective articles and tutorials on a wide variety of financial topics.
Free Annual Reports
